The benefits of incorporating HPMC into pharmaceutical formulations are manifold. By utilizing HPMC as a matrix former in sustained-release dosage forms, pharmaceutical manufacturers can achieve precise control over drug release, leading to optimized therapeutic outcomes and minimized side effects. Furthermore, HPMC’s bioadhesive properties make it suitable for use in ophthalmic formulations, enhancing the contact time of drugs with ocular tissues and improving the efficacy of treatments for conditions such as glaucoma and dry eye syndrome. Additionally, HPMC’s compatibility with a variety of active pharmaceutical ingredients and its ability to enhance solubility and bioavailability further contribute to its value in pharmaceutical applications, making it a preferred choice for formulators seeking to develop safe, effective, and patient-friendly drug products.